BARDA RRPV RFI Seeks Partners for BSL4 Studies and Support Services
Overview of the Opportunity The Biomedical Advanced Research and Development Authority (BARDA), through the Rapid Response Partnership Vehicle (RRPV), has released a new Request for Information (RFI) titled “Biosafety Level 4 Preclinical and Nonclinical Support for Medical Countermeasure Development (BSL4)”. Issued July 9, 2026, the RFI is a market research exercise to map out who can deliver preclinical and nonclinical […]
BARDA RRPV RFI Seeks Partners for BSL4 Studies and Support Services Read More »